🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 12 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/02/2013 | 56,80 | 57,07 | 56,09 | 56,86 | +0,28% | 1,73% | 612.000 |
| 15/02/2013 | 56,41 | 57,68 | 56,04 | 56,70 | +1,07% | 2,91% | 687.600 |
| 14/02/2013 | 56,00 | 58,11 | 55,52 | 56,10 | +4,26% | 4,62% | 1.994.300 |
| 13/02/2013 | 53,91 | 54,01 | 52,98 | 53,81 | +0,00% | 1,91% | 336.300 |
| 12/02/2013 | 53,18 | 53,98 | 53,18 | 53,81 | +0,75% | 1,50% | 349.300 |
| 11/02/2013 | 53,89 | 54,09 | 53,16 | 53,41 | -0,65% | 1,73% | 375.200 |
| 08/02/2013 | 53,80 | 54,08 | 53,51 | 53,76 | +0,28% | 1,06% | 536.200 |
| 07/02/2013 | 54,43 | 54,72 | 53,43 | 53,61 | -1,74% | 2,37% | 415.000 |
| 06/02/2013 | 54,69 | 55,28 | 54,44 | 54,56 | -0,44% | 1,54% | 401.000 |
| 05/02/2013 | 53,99 | 55,18 | 53,73 | 54,80 | +2,62% | 2,69% | 1.034.900 |
| 04/02/2013 | 54,10 | 54,92 | 53,32 | 53,40 | -0,73% | 2,96% | 1.186.400 |
| 01/02/2013 | 54,04 | 54,77 | 53,50 | 53,79 | -0,19% | 2,35% | 417.700 |
| 31/01/2013 | 53,50 | 54,20 | 53,50 | 53,89 | +0,75% | 1,31% | 648.600 |
| 30/01/2013 | 53,34 | 53,83 | 53,21 | 53,49 | +0,39% | 1,16% | 473.300 |
| 29/01/2013 | 53,07 | 53,48 | 52,77 | 53,28 | +0,89% | 1,34% | 425.500 |
| 28/01/2013 | 53,50 | 53,60 | 52,38 | 52,81 | -1,31% | 2,28% | 338.900 |
| 25/01/2013 | 53,41 | 53,65 | 53,12 | 53,51 | +0,64% | 0,99% | 241.600 |
| 24/01/2013 | 52,73 | 53,58 | 52,73 | 53,17 | +0,83% | 1,61% | 320.100 |
| 23/01/2013 | 53,29 | 53,50 | 52,57 | 52,73 | -1,35% | 1,75% | 438.500 |
| 22/01/2013 | 52,00 | 53,54 | 52,00 | 53,45 | +2,57% | 2,96% | 413.600 |
| 18/01/2013 | 52,42 | 52,42 | 51,82 | 52,11 | -0,17% | 1,14% | 511.100 |
| 17/01/2013 | 52,11 | 53,15 | 51,38 | 52,20 | +1,08% | 3,40% | 501.500 |
| 16/01/2013 | 51,90 | 52,09 | 51,52 | 51,64 | -0,52% | 1,10% | 486.400 |
| 15/01/2013 | 51,80 | 52,05 | 51,75 | 51,91 | -0,40% | 0,58% | 424.000 |
| 14/01/2013 | 52,19 | 52,39 | 51,74 | 52,12 | -0,10% | 1,25% | 364.400 |
| 11/01/2013 | 52,64 | 52,93 | 52,03 | 52,17 | -0,69% | 1,71% | 471.100 |
| 10/01/2013 | 53,11 | 53,32 | 52,42 | 52,53 | -0,72% | 1,69% | 445.900 |
| 09/01/2013 | 52,98 | 53,28 | 52,51 | 52,91 | +0,51% | 1,45% | 556.000 |
| 08/01/2013 | 52,95 | 53,50 | 52,55 | 52,64 | -0,53% | 1,79% | 597.100 |
| 07/01/2013 | 51,97 | 53,14 | 51,97 | 52,92 | +1,83% | 2,25% | 739.600 |